TrialEBioMedicine2026

Estimated efficacy of the adjuvanted RSVPreF3 vaccine against diverse and worldwide predominant RSV strains, irrespective of RSV F protein variation: results of a post-hoc analysis from the AReSVi-006 trial.

Jonathan De Smedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.